Common use of Sales Force Incentive Compensation for POI Products Clause in Contracts

Sales Force Incentive Compensation for POI Products. Each --------------------------------------------------- Party shall offer incentive compensation to its Sales Representatives with respect to the sale of the POI Product in the United States for each Calendar Year during the Adolor Product Promotion Term. Such incentive schemes shall be adopted by each Party in a manner consistent with the way other incentive schemes are adopted within their respective organizations; provided, however, that the incentive arrangement adopted by ** for its Sales Representatives ** the POI Product (a) in the first ** day period (or other period as applicable ending on the last day of the GSK quarterly sales incentive calculation cycle which falls most closely in time to the end of such ** day period) after ** of the POI Product in the ** (the "Initial Incentive Period"), shall be structured such that not less than ** percent (**%) of the ** for incentive ** = Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. compensation available to such Sales Representatives in that period shall be ** for the POI Product, and (b) in the ** (**) month period following the Initial Incentive Period, shall be structured such that not less than ** percent (**%) of the ** for incentive compensation available to such Sales Representatives in that period shall be ** for the POI Product. Each Party shall notify the other Party, prior to the First Commercial Sale and prior to the commencement of each Calendar Year thereafter, of the structure, formula and relative competitiveness of such arrangement (having regard to other such arrangements adopted by GSK, Adolor, or other companies in the pharmaceutical industry for a company similar in size and scope to such Party).

Sales Force Incentive Compensation for POI Products. Each --------------------------------------------------- Party shall offer incentive compensation Incentive Compensation to its Sales Representatives with respect to the sale of the POI Product in the United States for each Calendar Year during the Adolor Product Promotion Term. Such incentive schemes shall be adopted by each Party in a manner consistent with the way other incentive schemes are adopted within their respective organizations; provided, however, that that, for the incentive arrangement adopted by first [** for its Sales Representatives ** ] months after the First Commercial Sale of the POI Product (a) in Product, the first ** day period (or other period as applicable ending on the last day of the GSK quarterly Incentive Compensation available to be earned for sales incentive calculation cycle which falls most closely in time to the end of such ** day period) after ** of the POI Product in by a Surgical Account Manager who Details the ** (the "Initial Incentive Period")POI Product, shall be structured such that not no less than ** percent ([**%) of the ] [** for incentive ** ] = Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. compensation ([**]%) of the Incentive Compensation available to be earned by such Sales Representatives in that period shall be ** Surgical Account Manager. Additionally, for Detailing the POI Product, and (b) in the ** (Incentive Compensation payable by GSK to Hospital Account Managers shall be no less than [**) month period following the Initial Incentive Period, shall be structured such that not less than ** ] percent ([**]%) of the ** for incentive compensation total Incentive Compensation available to such Sales Representatives in that period shall be ** Hospital Account Managers and, provided, that, GSK will not provide an incentive greater than the Incentive Compensation for the POI Product for any other product detailed by the Hospital Account Managers who also Detail the POI Product. Each Party shall notify the other Party, prior to the First Commercial Sale and prior to the commencement of each Calendar Year thereafter, of the structure, formula and relative competitiveness of such arrangement (having regard to other such arrangements adopted by GSK, Adolor, or other companies in the pharmaceutical industry for a company similar in size and scope to such Party).

Sales Force Incentive Compensation for POI Products. Each --------------------------------------------------- Party shall offer incentive compensation Incentive Compensation to its Sales Representatives with respect to the sale of the POI Product in the United States for each Calendar Year during the Adolor Product Promotion Term. Such incentive schemes shall be adopted by each Party in a manner consistent with the way other incentive schemes are adopted within their respective organizations; provided, however, that that, for the incentive arrangement adopted by first [** for its Sales Representatives ** ] months after the First Commercial Sale of the POI Product (a) in Product, the first ** day period (or other period as applicable ending on the last day of the GSK quarterly Incentive Compensation available to be earned for sales incentive calculation cycle which falls most closely in time to the end of such ** day period) after ** of the POI Product in by a Surgical Account Manager who Details the ** (the "Initial Incentive Period")POI Product, shall be structured such that not no less than ** percent ([**] ([**]%) of the ** for incentive ** = Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. compensation Incentive Compensation available to be earned by such Sales Representatives in that period shall be ** Surgical Account Manager. Additionally, for Detailing the POI Product, and (b) in the ** (Incentive Compensation payable by GSK to Hospital Account Managers shall be no less than [**) month period following the Initial Incentive Period, shall be structured such that not less than ** ] percent ([**]%) of the ** for incentive compensation total Incentive Compensation available to such Sales Representatives in that period shall be ** Hospital Account Managers and, provided, that, GSK will not provide an incentive greater than the Incentive Compensation for the POI Product for any other product detailed by the Hospital Account Managers who also Detail the POI Product. Each Party shall notify the other Party, prior to the First Commercial Sale and prior to the commencement of each Calendar Year thereafter, of the structure, formula and relative competitiveness of such arrangement (having regard to other such arrangements adopted by GSK, Adolor, or other companies in the pharmaceutical industry for a company similar in size and scope to such Party). [**] = Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.